Enzyme deficiency protects hepatitis C patients from treatment-related anemia

Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether. But now, scientists have discovered two genetic alterations linked to a benign enzyme condition that keep some patients anemia-free.

Read the whole article on Science Daily

More from Science Daily